|
CAMTA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.955600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.247500E-02 |
| Normal-vs-Stage2 |
5.060000E-03 |
| Normal-vs-Stage3 |
3.038000E-04 |
| Normal-vs-Stage4 |
3.289900E-02 |
| Stage1-vs-Stage2 |
5.316400E-02 |
| Stage1-vs-Stage3 |
6.797400E-03 |
| Stage1-vs-Stage4 |
7.027800E-02 |
| Stage2-vs-Stage3 |
7.347600E-01 |
| Stage2-vs-Stage4 |
7.797000E-01 |
| Stage3-vs-Stage4 |
9.739200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.986800E-04 |
| Normal-vs-AfricanAmerican |
3.297800E-02 |
| Normal-vs-Asian |
3.622600E-01 |
| Caucasian-vs-AfricanAmerican |
5.457200E-01 |
| Caucasian-vs-Asian |
7.075000E-01 |
| AfricanAmerican-vs-Asian |
6.090600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.576010E-03 |
| Normal-vs-Female |
9.572400E-04 |
| Male-vs-Female |
3.807000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.800400E-02 |
| Normal-vs-Extreme_Weight |
3.594300E-02 |
| Normal-vs-Obese |
8.592200E-04 |
| Normal-vs-Extreme_Obese |
3.172500E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.026400E-01 |
| Normal_Weight-vs-Obese |
4.116000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.156200E-01 |
| Extreme_Weight-vs-Obese |
1.184760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.833400E-01 |
| Obese-vs-Extreme_Obese |
9.035400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.847600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.078070E-03 |
| Normal-vs-Age(61-80Yrs) |
3.356600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.752000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.430200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.029800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.918200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.125800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.643800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.113200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.422800E-01 |
| Normal-VS-Type2 PRCC |
5.77619999608814E-08 |
| Normal-VS-KIRP CIMP |
1.24109999999344E-06 |
| Normal-VS-Unclassified PRCC |
2.353300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.48159995383423E-09 |
| Type1 PRCC-VS-KIRP CIMP |
3.81520000000135E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
9.150400E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.266000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.081400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.416400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.496750E-03 |
| Normal-vs-N1 |
3.22869999624942E-08 |
| Normal-vs-N2 |
3.661200E-03 |
| N0-vs-N1 |
1.601810E-02 |
| N0-vs-N2 |
3.648200E-01 |
| N1-vs-N2 |
9.659800E-01 |
|
|
